Dermatological ECP flowchart
Use this flowchart to check if your extemporaneously compounded dermatological product is funded.
For an ECP to be subsidised, it must contain 2 or more subsidised component pharmaceuticals listed in the Schedule.
- Dermatological ECP Flowchart (2020) [PDF 367 KB]
* Hydrocortisone powder is subsidised only in combination with a barrier cream/emollient, not with a proprietary topical corticosteroid-plain.
Dermatological bases are all pharmaceuticals listed under “barrier creams and emollients” in the Schedule
Proprietary topical corticosteroids-plain are subsidised dermatological bases that may be diluted with another dermatological base.
Collodion flexible is dermatological base.
Dermatological galenical is identified in the Schedule with the restriction:
- only in combination with a dermatological base or proprietary topical corticosteroid-plain
- with or without other dermatological galenicals.
Who to contact
If you have any questions, email firstname.lastname@example.org